Advertisement

Interferons and Their Roles in Virus Infections

  • William E. StewartII
Chapter
  • 48 Downloads
Part of the University of South Florida International Biomedical Symposia Series book series (USFIBSS)

Abstract

Interferons (IFNs) were originally identified by virologists who were looking for a virus-induced virus-inhibitory factor (1) and this induction-action relationship seemed to suggest that interferon’s reason for being was to inhibit viruses. This simple relationship was quite comforting for several years, but it then started to get more complex by the observations that IFNs could induce a number of alterations in cells besides inhibition of virus replication (2). Such “non-antiviral activities” of IFNs (3) were for several years dismissed as attributable to impurities in the usually relatively crude IFN preparations, but eventually it was substantiated that IFNs are potent inducers of a number of seemingly unrelated “pleotypic alterations” in various cells (4).

Keywords

Gamma IFNs Beta IFNs South Florida College Inhibit Virus Infection Inducer Activity Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    A. Isaacs and J. Lindenmann, Virus interference. I. The interferon, Proc. Royal Soc. B 147: 258 (1957).CrossRefGoogle Scholar
  2. 2.
    W. E. Stewart II, “The Interferon System,” Springer-Verlag, Vienna, Austria (1981).Google Scholar
  3. 3.
    W. E. Stewart II, L. B. Gosser, and R. Z. Lockart, Priming: a nonanti viral function of interferon, J. Virol. 7: 792 (1971).PubMedGoogle Scholar
  4. 4.
    W. E. Stewart II, E. DeClercq, P. DeSomer, K. Berg, C. A. Ogburn, and K. Paucker, Antiviral and non-antiviral activity of highly purified interferon, Nature 246: 141 (1973).CrossRefGoogle Scholar
  5. 5.
    W. E. Stewart II, J. E. Blalock, D. C. Burke, C. Chany, J. Dunnick, E. Falcoff, R. M. Friedman, G. J. Galasso, W. K. Joklik, J. Vilcek, J. S. Youngner, and K. C. Zoon, Interferon nomenclature, Nature 286: 110 (1980).CrossRefGoogle Scholar
  6. 6.
    W. E. Stewart II and D. K. Blanchard, Interferons: cytostatic and immunomodulatory effects, in: “Immunity to Cancer,” A. Reif and M. Mitchell, eds., Academic Press, New York (1985).Google Scholar
  7. 7.
    W. E. Stewart II, Heterogeneities of human interferons, in: “Biological Responses in Cancer,” E. Mihich, ed., Plenum Publishing Corporation, New York (1984).Google Scholar
  8. 8.
    S. B. Greenberg and Harmon, Clinical use of interferons: localized application in viral diseases, in: “Interferons and Their Applications,” P. E. Came and W. A. Carter, eds., Springer-Verlag, Berlin (1984).Google Scholar
  9. 9.
    W. E. Stewart II and S. E. Sulkin, Interferon production in hamsters experimentally infected with rabies virus, Proc. Soc. Exp. Biol. Med. 123: 650 (1966).PubMedGoogle Scholar
  10. 10.
    J. P. Luby, W. E. Stewart II, S. E. Sulkin, and J. P. Sanford, Interferon in human infections with St. Louis encephalitis, Ann. Int. Med. 71: 703 (1969).PubMedGoogle Scholar
  11. 11.
    I. Gresser, Can interferon induce disease?, in: “Interferon 4,” I. Gresser, ed., Academic Press, London (1982).Google Scholar
  12. 12.
    B. Lebleu and J. Content, Mechanisms of interferon action: biochemical and genetic approaches, in: “Interferon 4, ” I. Gresser, ed., Academic Press, London (1982).Google Scholar
  13. 13.
    W. E. Stewart II, The natural recovery process from acute virus infection, in: “Selective Inhibitors of Viral Functions,” W. A. Carter, ed., CRC Press, Cleveland (1973).Google Scholar
  14. 14.
    H. Strander, K. Cantell, G. Carlstrom, S. Ingimarsson, P. A. Jakobsson, U. Nilsonne, Acute infections in interferon-treated patients with osteosarcoma: a preliminary report of a comparative study, J. Infect. Dis. 133: A245 (1976).PubMedCrossRefGoogle Scholar
  15. 15.
    G. M. Scott, W. E. Stewart II, D. A. J. Tyrrell, K. Cantell, T. Cartwright, and V. G. Edy, Skin reactions to interferon inoculations are reduced but not abolished by purification, J. Interferon Res. 1: 79 (1980).PubMedCrossRefGoogle Scholar
  16. 16.
    D. A. J. Tyrrell, Some thoughts on the clinical exploitation of interferon in infectious diseases, in: “Interferon 4,” I. Gresser, ed., Academic Press, London (1982).Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • William E. StewartII
    • 1
  1. 1.Department of Medical Microbiology and ImmunologyUniversity of South Florida College of MedicineTampaUSA

Personalised recommendations